Biotech Values

[Biowatch]

SRDX/MRK I thought $20 million upfront was small change from your viewpoint, especially when coupled with the option to walk away.

Yes, I concede that it sounds like sour grapes on my part, and the MRK/PYY deal is not the only one you've criticized for having a minimal upfront commitment.

Clearly MRK wants to take the SRDX technology for a test drive, and if it works it could open many pathways, but I wonder what the terms are if they score a hit.

P.S., SRDX is up around 42% in 2007, so they haven't been a sleeper stock...